Publications
The Center exists in part to create original evidence and information that support and advance conversations around professionalism, value, and other health care issues.
READ about scientific publications, briefs, and reports emerging from the Center and its collaborators below.
Designing Future State to Account for Social Risk in CMS Payments
- Robert L. Phillips Jr., MD, MSPH
- Andrew W. Bazemore, MD, MPH
Submitted on: January, 2021
This invitation only workshop is a one, full-day brainstorming event to design a future state CMS payment system that incorporates social risk in a sustainable, equitable way. This convening of CMS, ASPE, safety net health plan, clinician, state, and patient stakeholders provides the unique opportunity to collaboratively design potential new approaches to risk adjustment for the Medicare and Medicaid programs.
Distribution of Physician Specialties by Rurality
- Tyler Barreto, MD, MPH
- Anuradha Jetty, MPH
- Aimee R. Eden, PhD, MPH
- Steven Petterson, PhD
- Andrew W. Bazemore, MD, MPH
- Lars E. Peterson, MD, PhD
Submitted on: December, 2020
Taking a Closer Look at Mental Health Treatment Differences: Effectiveness of Mental Health Treatment by Provider Type in Racial and Ethnic Minorities
- Tracey L. Henry
- Anuradha Jetty
- Stephen Petterson
- Helaina Jaffree
- Allie Ramsay
- Erica Heiman
- Andrew Bazemore
Submitted on: October, 2020
Major depressive disorders are a major cause of disability-adjusted life years (DALYs) lost in the U.S. Additionally, depression will be 1 of the 3 leading causes of disability in the developed world by 2030. In 2017, the U.S. spent $183 billion on mental and substance use disorders, a figure likely to rise with continued population growth and aging. However, the greatest costs often cannot be directly measured, and include lost productivity/economic output, decreased quality of life, increased need for social support services, increased housing instability, and increased burden on caregivers. The World Economic Forum study has estimated global cost in lost economic output could reach $16 trillion in the next 20 years. Despite this, treatment rates remain low, with large disparities in treatment access and utilization especially in racial/ethnic minorities.
